<div class="bk-sec"><div><table class="default-table glossary"><tbody>
<tr>
<td>ACR20</td>
<td>American College of Rheumatology criteria</td>
</tr>
<tr>
<td>ASTRAEA</td>
<td>Active pSoriaTic aRthritis rAndomizEd triAl</td>
</tr>
<tr>
<td>bDMARDS</td>
<td>Biologic disease-modifying anti-rheumatic drugs</td>
</tr>
<tr>
<td>BP</td>
<td>Bodily pain</td>
</tr>
<tr>
<td>BSA</td>
<td>Body surface area</td>
</tr>
<tr>
<td>CASPAR</td>
<td>Classification Criteria for Psoriatic Arthritis</td>
</tr>
<tr>
<td>CI</td>
<td>Confidence interval</td>
</tr>
<tr>
<td>CRP</td>
<td>C-reactive protein</td>
</tr>
<tr>
<td>DLQI</td>
<td>Dermatology Life Quality Index</td>
</tr>
<tr>
<td>DMARD</td>
<td>Disease-modifying antirheumatic drug</td>
</tr>
<tr>
<td>EE</td>
<td>Early escape</td>
</tr>
<tr>
<td>FACIT-F</td>
<td>Functional Assessment of Chronic Illness Therapy-Fatigue</td>
</tr>
<tr>
<td>GH</td>
<td>General health</td>
</tr>
<tr>
<td>HAQ-DI</td>
<td>Health Assessment Questionnaire-Disability Index</td>
</tr>
<tr>
<td>HRQoL</td>
<td>Health-related quality of life</td>
</tr>
<tr>
<td>MCID</td>
<td>Minimal clinically important difference</td>
</tr>
<tr>
<td>MCS</td>
<td>Mental component summary</td>
</tr>
<tr>
<td>MH</td>
<td>Mental health</td>
</tr>
<tr>
<td>MTX</td>
<td>Methotrexate</td>
</tr>
<tr>
<td>NV</td>
<td>Normative values</td>
</tr>
<tr>
<td>PCS</td>
<td>Physical component summary</td>
</tr>
<tr>
<td>PF</td>
<td>Physical functioning</td>
</tr>
<tr>
<td>PRO</td>
<td>Patient-reported outcome</td>
</tr>
<tr>
<td>PsA</td>
<td>Psoriatic arthritis</td>
</tr>
<tr>
<td>RE</td>
<td>Role–emotional</td>
</tr>
<tr>
<td>RP</td>
<td>Role–physical</td>
</tr>
<tr>
<td>SC</td>
<td>Subcutaneous</td>
</tr>
<tr>
<td>SE</td>
<td>Standard error</td>
</tr>
<tr>
<td>SF-36</td>
<td>Short Form-36</td>
</tr>
<tr>
<td>TNFi</td>
<td>Tumour necrosis factor inhibitor</td>
</tr>
<tr>
<td>ULN</td>
<td>Upper limit of normal</td>
</tr>
<tr>
<td>VT</td>
<td>Vitality</td>
</tr>
</tbody></table></div></div>